DE69435227D1 - Cyclisch GMP bindende cyclisch GMP spezifische Phosphodiesterase Materialien und Verfahren - Google Patents

Cyclisch GMP bindende cyclisch GMP spezifische Phosphodiesterase Materialien und Verfahren

Info

Publication number
DE69435227D1
DE69435227D1 DE69435227T DE69435227T DE69435227D1 DE 69435227 D1 DE69435227 D1 DE 69435227D1 DE 69435227 T DE69435227 T DE 69435227T DE 69435227 T DE69435227 T DE 69435227T DE 69435227 D1 DE69435227 D1 DE 69435227D1
Authority
DE
Germany
Prior art keywords
cyclic gmp
procedures
specific phosphodiesterase
binding
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69435227T
Other languages
English (en)
Inventor
Joseph A Beavo
Jackie D Corbin
Kenneth M Ferguson
Sharron H Francis
Ann Kadlecek
Kate Loughney
Linda M Mcallister-Lucas
William K Sonnenburg
Melissa K Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Icos Corp
Original Assignee
University of Washington
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22080121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69435227(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Washington, Icos Corp filed Critical University of Washington
Application granted granted Critical
Publication of DE69435227D1 publication Critical patent/DE69435227D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
DE69435227T 1993-05-27 1994-05-27 Cyclisch GMP bindende cyclisch GMP spezifische Phosphodiesterase Materialien und Verfahren Expired - Lifetime DE69435227D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6805193A 1993-05-27 1993-05-27

Publications (1)

Publication Number Publication Date
DE69435227D1 true DE69435227D1 (de) 2009-09-17

Family

ID=22080121

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69426804T Expired - Lifetime DE69426804T4 (de) 1993-05-27 1994-05-27 Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren.
DE69426804A Expired - Lifetime DE69426804D1 (de) 1993-05-27 1994-05-27 Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren.
DE69435227T Expired - Lifetime DE69435227D1 (de) 1993-05-27 1994-05-27 Cyclisch GMP bindende cyclisch GMP spezifische Phosphodiesterase Materialien und Verfahren

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69426804T Expired - Lifetime DE69426804T4 (de) 1993-05-27 1994-05-27 Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren.
DE69426804A Expired - Lifetime DE69426804D1 (de) 1993-05-27 1994-05-27 Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren.

Country Status (13)

Country Link
US (7) US5702936A (de)
EP (2) EP1038963B1 (de)
JP (3) JP4150070B2 (de)
AT (2) ATE199569T1 (de)
CA (3) CA2698716A1 (de)
DE (3) DE69426804T4 (de)
DK (2) DK1038963T3 (de)
ES (2) ES2333691T3 (de)
GR (1) GR3035616T3 (de)
HK (1) HK1013427A1 (de)
LV (1) LV12814B (de)
PT (2) PT652960E (de)
WO (1) WO1994028144A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060222647A1 (en) * 1993-05-27 2006-10-05 Beavo Joseph A Methods and compositions for modulating the activity of PDE5
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
WO1999042596A2 (en) * 1998-02-23 1999-08-26 Icos Corporation Phosphodiesterase 10
WO2000005383A1 (fr) * 1998-07-21 2000-02-03 Takeda Chemical Industries, Ltd. Nouvelle proteine et son adn
EP1133689A4 (de) * 1998-11-25 2002-10-30 Cell Pathways Inc Verfahren zum diagnostizieren von neoplasia
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
US6100037A (en) * 1999-01-07 2000-08-08 Incyte Pharmaceuticals, Inc. Human cyclic nucleotide PDEs
US6451807B1 (en) 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
US6146876A (en) * 1999-06-11 2000-11-14 Millennium Pharmaceuticals, Inc. 22025, a novel human cyclic nucleotide phosphodiesterase
US7098015B2 (en) * 1999-06-11 2006-08-29 Millennium Pharmaceuticals, Inc. 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
GB9922125D0 (en) 1999-09-17 1999-11-17 Pfizer Ltd Phosphodiesterase enzymes
CN1297049A (zh) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 一种新的多肽——人环磷酸鸟嘌呤抑制的磷酸二酯酶17和编码这种多肽的多核苷酸
JP2004500425A (ja) 2000-04-19 2004-01-08 リリー　アイコス　リミテッド　ライアビリティ　カンパニー パーキンソン病の処置に対する環状ｇｍｐ特異的ホスホジエステラーゼインヒビターの使用
GB0016009D0 (en) * 2000-06-29 2000-08-23 Pfizer Ltd Target
US6794192B2 (en) 2000-06-29 2004-09-21 Pfizer Inc. Target
US6846813B2 (en) * 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
US20030096864A1 (en) * 2000-06-30 2003-05-22 Fang Lawrence Y. Compounds to treat alzheimer's disease
ES2291362T3 (es) * 2000-09-14 2008-03-01 Mount Sinai School Of Medicine Procedimientos de cribado para identificar proteinas g y otros compuestos que modulan la actividad de la fosfodiesterasa (pde).
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
US20040219632A1 (en) * 2001-04-20 2004-11-04 Robert Margolskee T1r3 a novel taste receptor
US20070213407A1 (en) * 2001-06-29 2007-09-13 Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc Compounds to treat Alzheimer's disease
EP2351765A3 (de) 2001-07-10 2012-02-22 Lakewood-Amedex, Inc Oligonukleotidhaltige pharmakologische zusammensetzungen und deren verwendung
US20050202549A1 (en) * 2001-11-02 2005-09-15 Pfizer Inc Crystal structure
GB0126417D0 (en) * 2001-11-02 2002-01-02 Pfizer Ltd Crystal structure
US7304128B2 (en) * 2002-06-04 2007-12-04 E.I. Du Pont De Nemours And Company Carbon nanotube binding peptides
CA2522472A1 (en) * 2003-05-01 2004-11-11 Pfizer Inc. Crystal of pde5, its crystal structure and its use in drug design
JP2010004758A (ja) * 2008-06-24 2010-01-14 Probex Inc ｃｙｃｌｉｃＧＭＰ検出方法
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
KR101550217B1 (ko) * 2014-03-26 2015-09-04 전남대학교산학협력단 숙주세포의 생체 회로 간섭 없이 외래 유전자를 발현하기 위한 재조합 벡터 및 이의 용도
WO2017094885A1 (ja) * 2015-12-04 2017-06-08 国立大学法人東京大学 リガンド蛍光センサータンパク質とその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1290210B (de) * 1962-12-04 1969-03-06 Siemens Ag Vorrichtung zum maschinellen Verlegen und Anschliessen von Schaltdraehten
US4129349A (en) * 1975-11-10 1978-12-12 Bell Telephone Laboratories, Incorporated Quick-connect breadboarding system
JPH0797015B2 (ja) * 1988-10-28 1995-10-18 株式会社ピーエフユー 画像処理によるｓｍｄの位置補正方式
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
JPH038400A (ja) * 1989-06-06 1991-01-16 Sharp Corp プリント基板の位置補正方法
US5015637A (en) * 1990-05-25 1991-05-14 Hoechst-Roussel Pharmaceutical Inc. Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepines
ATE250629T1 (de) * 1991-04-19 2003-10-15 Univ Washington Für säugetierphosphodiesterasen kodierende dns
AU2580892A (en) * 1991-09-05 1993-04-05 Isis Pharmaceuticals, Inc. Determination of oligonucleotides for therapeutics, diagnostics and research reagents
US6403302B1 (en) * 1992-09-17 2002-06-11 California Institute Of Technology Methods and compositions for triple helix formation

Also Published As

Publication number Publication date
JP2010042035A (ja) 2010-02-25
CA2363537A1 (en) 1994-12-08
DE69426804T4 (de) 2005-10-13
WO1994028144A1 (en) 1994-12-08
LV12814B (lv) 2002-10-20
CA2141060C (en) 2002-02-19
LV12814A (en) 2002-04-20
EP1038963B1 (de) 2009-08-05
US20060216809A1 (en) 2006-09-28
US5955583A (en) 1999-09-21
JP4450767B2 (ja) 2010-04-14
EP0652960B1 (de) 2001-03-07
ATE199569T1 (de) 2001-03-15
ES2156898T3 (es) 2001-08-01
US5702936A (en) 1997-12-30
US20050196833A1 (en) 2005-09-08
DK1038963T3 (da) 2009-11-23
ES2333691T3 (es) 2010-02-26
US20030054992A1 (en) 2003-03-20
PT1038963E (pt) 2009-10-13
US6037119A (en) 2000-03-14
CA2698716A1 (en) 1994-12-08
US5652131A (en) 1997-07-29
DK0652960T3 (da) 2001-04-17
DE69426804T2 (de) 2001-07-19
GR3035616T3 (en) 2001-06-29
JP4150070B2 (ja) 2008-09-17
ATE438723T1 (de) 2009-08-15
DE69426804D1 (de) 2001-04-12
JP2005245467A (ja) 2005-09-15
EP1038963A2 (de) 2000-09-27
CA2141060A1 (en) 1994-12-08
JPH08502900A (ja) 1996-04-02
EP1038963A3 (de) 2000-10-04
PT652960E (pt) 2001-08-30
EP0652960A1 (de) 1995-05-17
HK1013427A1 (en) 1999-08-27
CA2363537C (en) 2010-07-06
EP0652960B9 (de) 2004-10-27

Similar Documents

Publication Publication Date Title
DE69435227D1 (de) Cyclisch GMP bindende cyclisch GMP spezifische Phosphodiesterase Materialien und Verfahren
DK0535216T3 (da) DNA. der koder mammale phosphodiesteraser
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
ATE376590T1 (de) Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie
PT85237A (en) Process for the preparation of alkylnylamino-nucleotides
IL195812A0 (en) Human tslp dna and polypeptides
NZ315514A (en) Tumour necrosis factor associated factor (traf) inhibitors including traf polypeptide, murine nucleotide sequence and associated assays
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
EP0546087A4 (de)
EP0897011A3 (de) Arginin Deiminase
HU9204037D0 (en) Recombinant dna molecules coding activity of bacillus p-nitrobenzyl esterase and expression vectors thereof
WO2002077220A3 (en) Nucleic acids encoding human est1 proteins
EP0913479A3 (de) Adenin Glycosylase
DE69827532D1 (de) Polypeptide und dafür kodierende Nukleinsäure

Legal Events

Date Code Title Description
8364 No opposition during term of opposition